AminoMedixTM for Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT): Phase I, II Clinical Trial
Latest Information Update: 29 Mar 2023
At a glance
- Drugs Amifostine/amino acids (Primary)
- Indications Radiation sickness
- Focus Therapeutic Use
- 06 Nov 2016 New trial record